Agilent Technologies, Inc.

Agilent Technologies, Inc.

AยทNYSE

$137.40

+0.99%
HealthcareMedical - Diagnostics & Research

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

At a Glance

Live Snapshot
Market Cap$38.83B
EPS4.5900
P/E Ratio29.93
Earnings Date08/26/2026
Agilent Technologies, Inc.

Agilent Technologies, Inc. Fair Value Envelope

A ยท NYSE

Our analysis suggests that A has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $137.4, this represents a potential HIDDEN relative to our calculated worth for Agilent Technologies, Inc..

Intrinsic Value
Current Price: $137.4

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value$6.7B
+ Cash & Equivalents$1.8B
Firm Value$8.5B
- Debt$3.4B
Equity Value$5.2B
/ Shares Outstanding283,524,208B
DCF Value$18
OVERVALUED BY 87%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
$1.3B
$1.1B
$920.9M
$772.6M
$648.3M
$543.9M
$456.4M
$382.9M
$321.3M
$269.6M
Maintenance CapEx
-$68.3M
-$57.3M
-$48.1M
-$40.3M
-$33.8M
-$28.4M
-$23.8M
-$20.0M
-$16.8M
-$14.1M
Owner Earnings
$1.2B
$1.0B
$872.8M
$732.3M
$614.4M
$515.5M
$432.5M
$362.9M
$304.5M
$255.5M
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
$1.1B
$891.8M
$692.8M
$538.3M
$418.2M
$324.9M
$252.4M
$196.1M
$152.3M
$118.3M
Terminal Value represents 29.8% of Enterprise Value